study evaluated the effect of trans-epicardial BM cell transplantation in a porcine nonrep&used myocardial infarction model.
Methods:
In 14 domestic pigs, myocardial infarction was created by occludmg the first diagonal artery with coils. Twenty-eight days later, Iliac crest BM cells were aspirated, filtered, labeled with bromodeoxyuridine (BrdU) and cultured for 46 hrs Injections of 0.2 ml (-1.5 million cells/ml) (BM. n=l 1 pigs and saline, n=3 pigs) were evenly distributed lcm apart in the scar (6 injections) and around the scar (6 InJections). Animals were sacrificed at 4 (n=3), 14 (n=4) and 28 days (n=7) for histology and immunohistochsmistry analysis. and tunneled Into the muscle. Ischemiclnormal limb blood flow was measured using a laser Doppler blood flowmeter once a week, tissues were analyzed for smooth muscle actin and factor-6. DM mice were compared to normal mice.
Results: In normal mice, a faster restoratIon of blood flow was observed in the VEGF treated, however in the DM mice, there was no difference in the rate of flow restoration between the VEGF-treated or placebo-treated arm (graph). The blood flow was almost complete for the normal mice but reached a ratio of 0.6-0.9 for both DM arms and for normal placebo. The blood vessel density was higher for the both DM arms compared to the normal mice. infection induces the pro-inflammatory cytokine interleukin-6 (IL-6), which in turn induces "pro-atherosclerotic" changes in vascular endothelial cells (ECs).
Methods: ELISA was used to determine the levels of monocyte chemoattractant protein-1 (MCP-1) in the supernatant of mouse and human ECs incubated with IL-6, and IL-6 levels I" supematants of splenocytes, derived from CMV infected and unmfected mice, stimulated with mouse CMV antigens.
Results: IL-6 Induced, in a dose response fashion, MCP-1 expression in human ECs: 0, 2, 10, and 50 pg/ml IL-6 increased MCP-1 levels in EC conditioned medium from 1120+65, to 1148+105. 1395i40, and 2119*130 pg/ml, respectively, (P trend < 0.001).
IL-6 also induced MCP-1 expression in mouse ECs (p<O.O02). Importantly, IL-6 concentration in the supernatants of splenocyies stimulated with CMV antigens rose from undetectable levels in uninfected mice to14.925 pglml in the infected mice (P<O.O4).
Conclusions: These results suggest a previously unrecognized, but potentially important mechanism whereby CMV, and other pathogens, contribute to atherogenesls:
T-lymphocytes, clonally expanded in response to antigens presented by CMV infection, home to sites of vascular injury and locally release IL-6 when presented with either pathogen antigens that may be present in the plaque, or when they cross-react with host peptides homologous to the relevant pathogen antlgens; IL-6 then triggers ECs to release MCP-1, which recruits more monocytes and T-cells into the vessel wall and thereby exacerbates local inflammation, and thus atherogenesis.
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Induced by Human Hepatocyte Growth Factor Gene Without Nitric Oxide Synthesis in a Rat lschemic Hindlimb Model
Makoto lshizawa Koji Ohmori, Takahisa Noma, Teppei Tsuji, Kazushi Murakami, Tsunetatsu Namba, Katsufumi Mizushlge, Ryulchi Monshita, Yasufumi Kaneda.
Masakazu Kohno, Kagawa Medical University, Kagawa. Japan, Osaka University Medical School, Suita, Japan Background:Vascular endothelial growth factor has been reported that it has the effect of angiogenesis through the nitric oxide (NO). Hepatocyte growth factor (HGF) has also been reported to have the effect of anglogenesis. However, it has not been reported whether HGF induces anglogenesis through the NO. In this study, we examined the feasibility of gene therapy using the HGF gene to treat peripheral arierlal disease model rat in chronically inhibition of NO synthesis. Methods: L-NAME (NO synthesis inhibitor) was obtained by drinking water (Img/ml) from before resection of left femoral artery throughout this expenment. Sprague-Dawley rats were divided into three groups, which were transfected Human HGF naked plasmid DNA vector (5OOflg) or control vector (5O@g) with L-NAME administration, and control vector without L-NAME administration.
The naked plasmid was transfected Into an ischemtc hindlimb by intramuscular injection at 1 week after resection. At 4 weeks after transfection, angiogenesis were assessed by angiography and tissue capillary density.
Results:At 4 weeks after transfection. blood pressure was significantly increased in rats administrated with L-NAME. but HGF transfection by intramuscular Injection was not effect on blood pressure. The human HGF vector transfected rats administrated with L-NAME was resulted in significant increase in peripheral blood flow assessed by angiography compared with control vector administrated with L-NAME. Consistent with the increase in blood flow, a significant increase in tissue capillary number could be detected
